ArticleThe Journal of infectious diseases2017

Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.

Shashank Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.